Cannabis Science Inc (CBIS) 0.0294 $CBIS Cannabis

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Cannabis Science Inc (CBIS) 0.0294 $CBIS

Cannabis Chemistry: A Look at Vape Holdings' Scientific Approach
ACCESSWIRE - Tue May 12, 8:58AM CDT
WHITEFISH, MT / ACCESSWIRE / May 12, 2015 / The legal cannabis industry generated about $2.7 billion in revenue in 2014, according to ArcView Market Research. With that figure expected to grow at a double-digit rate over the coming decade, there has been no shortage of companies entering the space. Some companies, like Cannabis Science Inc. (PINKSHEETS: CBIS) and GW Pharmaceuticals (NASDAQ: GWPH) are focused on pharmaceutical opportunities, while others like Agritek Holdings Inc. (OTC: AGTK) are focused on branding and real estate.
GWPH: 112.25 (-0.07), DD: 70.25 (+0.58)

Cannabis Science Acquires Pet Care Manufacturer and Distributor Equi-Pharm & Enters the $60 Billion Pet Care Industry
PR Newswire - Thu May 07, 11:58AM CDT
Cannabis Science, Inc. (OTC: CBIS), a U.S. company specializing in the development of cannabis-based medicine and related consulting, is pleased to announce the acquisition of Equi-Pharm LLC, a USA manufacturer and distributor of specialty horse and pet grooming and topical applications. The acquisition incorporates an extensive expansion plan for Equi-Pharm including "Large Animal" such as horses, cattle, sheep and the like and "Small Animal" or "Pets" include cats, dogs, pet snakes and the like for medical and cosmetic products.

Cannabis Science (CBIS) Accepted To Present at ICAR 2015
PR Newswire - Wed Apr 22, 7:27AM CDT
Cannabis Science, Inc. (OTCQB: CBIS), a U.S. company specializing in the development of cannabis-based medicine and related consulting, is pleased to announce the acceptance of its presentation next month at the 28th International Conference on Antiviral Research (ICAR) in Rome, Italy.

Reviews Of 15 Marijuana Stocks Before The Marijuana Investor Summit - Part II
Anthony Cataldo - at Seeking Alpha - Thu Apr 16, 1:14AM CDT

CARA: 9.99 (-0.14)

Peak Pharma Prepares for Human Marketplace as Veterinary Segment Propels Early Commercial Success
ACCESSWIRE - Tue Apr 14, 8:15AM CDT
WHITEFISH, MT / ACCESSWIRE / April 14, 2015 / There's a growing and increasingly vocal body of researchers showing that cannabidiol ("CBD" - the non-psychoactive component of the cannabis plant - could provide substantial health benefits. While GW Pharmaceuticals plc (NASDAQ: GWPH) has pioneered clinical trials in the space, this research suggests that the company is just scratching the surface of what may be possible using natural phytocannabinoids.
VSI: 40.21 (+1.13), AMZN: 426.00 (-6.28), CARA: 9.99 (-0.14), HSKA: 29.13 (+0.11), PETS: 16.32 (+0.13), GWPH: 112.25 (-0.07), GNC: 44.63 (+0.70), WOOF: 52.13 (+0.37)

Subsidiary of ImmunoClin Corporation (IMCL) receives controlled drug license in the United Kingdom
PR Newswire - Thu Apr 02, 11:51AM CDT
ImmunoClin Corporation (OTC Markets: IMCL), a healthcare company specialized in personalized medicine, announces that its wholly owned subsidiary, ImmunoClin Ltd., received a controlled drug license from the UK government to possess, supply and produce schedule 1 drugs in its UK laboratory.

Cannabis Science (CBIS) Names Investor Relations Veteran Of Leading Companies To Head Its Investor Relations Initiatives
PR Newswire - Tue Mar 31, 7:37AM CDT
Cannabis Science, Inc. (OTCQB: CBIS) today announced it has entered into a one-year agreement with Derwin A. Wallace to provide financial and investor relations services for the Company. Mr. Wallace will focus on developing and expanding the Company's financial communications with the institutional and retail investment communities and initiate coverage from research analysts through a comprehensive financial and investor relations program.

Penny Stocks Buzz for Blue Water, Imageware Systems, Megola, Baltia Air Lines, Cannabis Science, and MEDL Mobile
PR Newswire - Mon Mar 30, 7:45AM CDT
Pennystocksinsiders.com (PSI) released FREE insider trading reports for US market investors to track the following active stocks and penny stocks: Blue Water (OTCBB: BLUU), Imageware Systems (OTCMKTS: IWSY), Megola (OTCMKTS: MGON), Baltia Air Lines (OTCMKTS: BLTA), Cannabis Science (OTCMKTS: CBIS), and MEDL Mobile (OTCMKTS: MEDL).

After Unveiling Its Products At Premiere Global Cannabis Event, Cannabis Science, Inc. Reports Strong Customer Interest
PR Newswire - Thu Mar 26, 9:09AM CDT
Choosing to present its products to the world at this year's Spannabis Fair, held March 20-22 in Barcelona, Spain, Cannabis Science, Inc. (OTCQB: CBIS) immediately began meeting with representatives of businesses and organizations interested in providing the products to their customers from across Spain.

Former National Institute Of Health (NIH) Scientist Allen A. Herman, M.B., Ch.B., Ph.D., Joins The Cannabis Science Scientific Advisory Board (SAB)
PR Newswire - Fri Mar 20, 10:01AM CDT
Cannabis Science, Inc. (OTCQB: CBIS), a U.S. company specializing in cannabis formulation-based drug development and related consulting, today announced that accomplished scholar, epidemiologist, and public health physician Allen A. Herman, M.B., Ch.B., Ph.D. has joined its scientific advisory board.

Cannabis Science (CBIS) Retains Cohen Grassroots Research Firm To Initiate Coverage Beginning With A 115-Page Analytical Report
PR Newswire - Wed Mar 18, 5:02AM CDT
Cannabis Science, Inc. (OTCQB: CBIS), a U.S. company specializing in cannabis formulation-based drug development and related consulting, today announced that Cohen Grassroots Research, Inc. (CGR), Wall Street's leading independent micro-cap and cannabis research firm, has been retained by the Company to initiate intricate analytical coverage of the Company.

Cannabis Science Subsidiary Michigan Green Technologies (MGT) Announces Key Progress With its Michigan State Initiatives & A New Advisory Board with Significant Board Members
PR Newswire - Fri Mar 13, 12:59PM CDT
Cannabis Science, Inc. (OTCQB: CBIS), a U.S. Company specializing in cannabis formulation-based drug development related consulting, is please to announce key progress with its subsidiary, Michigan Green Technologies.

Senators Propose Federal Medical Cannabis Bill; Would Eliminate Schedule 1 Status; Cannabis Stocks Rally
ACCESSWIRE - Thu Mar 12, 2:34PM CDT
LAKE FOREST, CA / ACCESSWIRE / March 12, 2015 / MJIC, Inc., a venture capital firm focused exclusively on the legal cannabis industry, is pleased to provide the following market update regarding breaking news impacting the market:

Cannabis Science (CBIS) Applauds 'Historic Step Forward For Nation's Suffering Patients' As U.S. Senate Introduces A Medical Marijuana Bill To End Federal Prohibition
PR Newswire - Wed Mar 11, 7:43AM CDT
Cannabis Science, Inc. (OTCQB: CBIS), a U.S. company specializing in the development of cannabis-based medicine, called today's introduction of a United States Senate bill that would end the federal ban on medical marijuana "a science-based blessing for patients across the United States" and a "common sense move that will contribute to significant new science-based research."

Cannabis Science Set to Release its First Line of European Products at Spannabis 2015, Taking Place in Barcelona, Spain from March 20th until the 22nd
PR Newswire - Mon Mar 09, 7:44AM CDT
Cannabis Science, Inc. (OTCQB: CBIS), a U.S. Company specializing in cannabis formulation-based drug development and related consulting, is pleased to announce it is set to release its first line of European products that will feature Cannabis Science proprietary formulations developed in Spain and the Netherlands at Spannabis 2015, taking place in Barcelona, Spain from March 20th until the 22nd, the largest Cannabis conference in the world. Other European markets will follow as jurisdictional laws permit.

6 Penny Stocks That Could Be Killing Your Portfolio Right Now
at The Street - Mon Mar 09, 7:17AM CDT
Openfolio surveyed the portfolios of its pool of over 20,000 investors to see the effect penny stocks have on overall performance.
APP: 0.58 (+0.02), ZNGA: 3.05 (unch)

Pot Stock Crash Redux: $23.3B Loss?
Matthew Finston - at Seeking Alpha - Sun Mar 08, 12:42AM CST


48 Marijuana Stocks - A Post-Mortem: Part II
Anthony Cataldo - at Seeking Alpha - Wed Mar 04, 7:36AM CST

INSY: 59.00 (+0.17), FULL: 3.52 (-0.01), CARA: 9.99 (-0.14)

CBIS Momentum Continues: Company Opens Call Center In Preparation For New Product Releases & CEO Shares His 'Impressive And Insightful' Views With Columnist
PR Newswire - Tue Mar 03, 8:03AM CST
Cannabis Science, Inc. (OTCQB: CBIS), a U.S. company specializing in the development of cannabis-based medicine, today announced two important developments: It launched its toll-free call center in preparation for its multiple global product launches, and CEO Raymond C. Dabney recently shared his industry views in the Chicago HR Examiner.

Is Now The Time To Pounce On The Pot Business?
Nicholas Kitonyi - at Seeking Alpha - Mon Mar 02, 2:09PM CST

GWPH: 112.25 (-0.07), ABBV: 65.99 (+0.02), BMY: 67.64 (+0.19)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Stitch AI Targets Banking’s Hardest Automation Gap

Updated Category News Views 46

The flashy chatbot stuff is cheap; banking permission to act is not. That is why Stitch AI’s launch deserves more attention than another vendor slapping “agentic” on a slide deck and calling it transformation. Banks do not need a machine to summarize a policy document while everyone applauds the demo. They need technology that can touch real workflows without...

Continue Reading
Ridgeline’s Dome Roof Award Signals Durable Craft Demand

Updated Category News Views 52

A faceted dome in the Alabama woods is about as far from a cookie-cutter reroof as it gets. Ridgeline Roofing & Restoration’s 2026 Excellence Award from Brava Roof Tile matters because the job in Pell City demanded the sort of painstaking field execution that separates a capable contractor from a crew merely moving shingles fast. Geometry Is Where Easy Claims Go to Die...

Continue Reading
Frosty Animatronics Put Nostalgia on Lowe's Shelves

Updated Category News Views 42

A moving corncob pipe is not anybody's idea of a macroeconomic signal, yet holiday aisles are built on precisely these little jolts of recognition. Gemmy has teamed with Warner Bros. Discovery Global Consumer Products to place a new animated Frosty the Snowman collection exclusively at Lowe's for the 2026 holiday season. It is cheerful retail business, not earthshaking...

Continue Reading
Rochester Truck Crashes Demand a Different Liability Map

Updated Category News Views 50

An 80,000-pound rig does not leave anybody the luxury of treating a wreck like a bent-fender dispute. That is the uncomfortable point behind Rochester attorney John Wright's discussion of truck crashes around I-390 and I-490. The physical damage may be obvious, but the legal story can be buried in dispatch systems, maintenance files, driver logs and corporate decisions...

Continue Reading
Specialty Chemicals Need Demand Before Capacity Bets

Updated Category News Views 16

Empty reactor space does not get filled because everybody suddenly loves reshoring. SOCMA's 2027 Contract Manufacturing Outlook makes that stubborn fact hard to dodge: nearly 70% of surveyed respondents expect North American manufacturing activity to rise over the next three years, yet 79.5% say stronger, more predictable customer demand is critical before future...

Continue Reading
Aimbient's OR Timestamp Study Puts Efficiency to Test

Updated Category News Views 0

A camera catching a patient’s arrival on time may sound mundane, but operating rooms are where mundane details can turn into serious money and better operational decisions. Aimbient’s newly corrected announcement points to an independently conducted Stanford Medicine study in JAMA Surgery that tested whether its computer-vision system could document key operating-room...

Continue Reading
Rosengart's Repeat Honor Signals Litigation Bench Depth

Updated Category News Views 23

Hollywood lawsuits rarely stay tucked inside a filing cabinet; they spill into headlines, contracts, careers, and sometimes a company's whole public posture. That is why Mathew S. Rosengart landing on The Hollywood Reporter's Top 25 Legal Troubleshooters list for a second straight year is more than a pleasant plaque for the office wall. It is a reminder that, in media and...

Continue Reading
Redseer's $5M Bet on Faster MENA Decision Intelligence

Updated Category News Views 65

Speed has become the expensive commodity in Middle Eastern commerce, and Redseer is putting roughly $5 million behind the idea that executives will pay to get it. Its newly launched Benchmarks MENA 2.0 platform combines proprietary market data with strategic advisory across nine MENA markets. That sounds like another corporate dashboard pitch until you consider the target...

Continue Reading
Parents Hand Kids Devices Years Before They Intended

Updated Category News Views 229

A nine-year-old with a smartphone used to raise eyebrows; this survey says it is increasingly the household baseline. All About Cookies, working with parental-control company Bark, surveyed U.S. parents and found that children typically receive personal devices well before their parents believe they should. That mismatch is not some cute little parenting contradiction. It...

Continue Reading
Litmus Gets $475 Million as Music Rights Mature Further

Updated Category News Views 48

Music royalties just got another serious pile of institutional money, and Litmus is holding the shovel. The company announced roughly $475 million of new capital commitments from Carlyle and investment funds managed by KKR, a notable vote of confidence in a platform that did not even exist before 2022. This is not some celebrity vanity vehicle buying a famous chorus and...

Continue Reading

Top 5 Most Recently Viewed Articles

Liberty Media Corp Achieves Milestone with Stock Surge

Updated Category News Views 203

Liberty Media Corporation Reaches New 52-Week High Liberty Media Corp (FWONA), a significant player in the media and entertainment sectors, has recently achieved a landmark 52-week high in its stock price, soaring to $75.71. This impressive rise has brought attention to the company's strong market performance, reflecting a substantial gain of 31.03% over the past year....

Continue Reading
Telegram's Pavel Durov Responds to Content Moderation Criticism

Updated Category News Views 200

Pavel Durov Addresses Concerns Over Telegram's Moderation Pavel Durov, the CEO of Telegram, has recently addressed the growing concerns about the platform’s moderation practices. In a message to his large audience of over 12 million subscribers, Durov pledged that the company would take steps to respond to the criticism regarding how Telegram handles content management....

Continue Reading
FiscalNote Expands Its Reach with New Public Sector Customers

Updated Category News Views 107

FiscalNote Expands Its Reach with New Public Sector Customers FiscalNote Holdings, Inc. (NYSE: NOTE), renowned for its AI-driven enterprise SaaS technologies, has recently made headlines by securing a myriad of new agreements across the U.S. public sector. These contracts span the federal government's three branches, showcasing the Company's celebrated suite of products...

Continue Reading
Bluejay Diagnostics to Showcase Symphony IL-6 Findings at SAEM

Updated Category News Views 117

Exciting Announcement from Bluejay Diagnostics Bluejay Diagnostics, Inc. (NASDAQ: BJDX) has recently made a remarkable announcement that will resonate within the medical community. This innovative healthcare company has had an abstract accepted for presentation at the Society of Academic Emergency Medicine (SAEM) Annual Meeting. This significant event is scheduled to take...

Continue Reading
Clean Maine Carbon Launches Biochar Carbon Credits Through Puro.earth

Updated Category News Views 334

Clean Maine Carbon's Groundbreaking Initiative Clean Maine Carbon (CMC) has taken a significant step forward in sustainable carbon removal by launching its first biochar CO2 Removal Certificates (CORCs). Teaming up with Flowcarbon as its carbon development partner, CMC's move marks a pivotal moment in the quest for innovative solutions to combat climate change. The Role...

Continue Reading